Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Dáil Éireann díospóireacht -
Tuesday, 18 Jun 2002

Vol. 553 No. 2

Written Answers. - Cancer Screening Programme.

Paul Connaughton

Ceist:

526 Mr. Connaughton asked the Minister for Health and Children the reason women in the Western Health Board area do not receive free cancer screening facilities; if other health boards provide this service free of charge; and if he will make a statement on the matter. [13255/02]

Since 1996, over €103 million has been invested in the development of cancer services under the national cancer strategy. In recognition of the need to further develop cancer services, the national health strategy has identified the need for the preparation by the end of this year of a revised implementation plan for the national cancer strategy. This plan is being prepared by my Department in conjunction with the National Cancer Forum and will set out the key areas to be targeted for the development of cancer services over the next seven years.

As part of this work, a sub-group of the National Cancer Forum has recently been established on generic screening. This group is currently reviewing all issues relating to screening, including looking at specific diseases such as prostate and colorectal cancer. Their recommendations will help to inform policy developments in this area on an ongoing basis.

As the Deputy is aware, BreastCheck, the national breast screening programme, commenced in March 2000 with phase one of the programme covering the Eastern Regional Health Authority, Midland Health Board and North-Eastern Health Board. Screening is being offered free of charge to all women in those areas in the target age group 50 to 64 years of age. It is expected that phase one of the programme will be completed by December 2002. To date, over 75,000 women have been called for screening and over 55,000 women have been screened, representing an uptake of 73%.

It is essential that the programme is driven by international quality assurance and best practice and the experience gained in phase one will facilitate the process of planning and organising the roll-out of the programme nationwide. All of the health boards are represented on the board of BreastCheck by their respective chief executive officers. My Department has been in ongoing consultation with BreastCheck concerning expansion of the programme and will continue to support BreastCheck in moving to nationwide coverage as soon as possible.
Phase One of the national cervical screening programme was launched in October 2000 covering the Mid-Western Health Board area. Under phase one, cervical screening is being offered free of charge, to approximately 67,000 women in the 25 to 60 age group, at five yearly intervals. As with BreastCheck, the importance of a national cervical screening programme which is underpinned by quality assurance and best practice is a key objective and the experience gained in phase one will facilitate the process of planning and organising the roll-out of this programme. Currently the chief executive officers of the health boards are involved in an examination of the feasibility and implications of extending the programme to the rest of the country.
Barr
Roinn